Renal Medullary Carcinoma Response to Chemotherapy: a Referral Center Experience in Brazil

Renal medullary carcinoma (RMC) is rare, accounting for less than 1% of all renal neoplasms. Case reports suggest RMC is highly aggressive, poorly responsive to chemotherapy, often metastatic at diagnosis, affects young men with sickle cell trait, and median overall survival (mOS) is less than 12 mo...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Maroja Silvino, Marina Cavalcanti, Venchiarutti Moniz, Camila Motta, Munhoz Piotto, Gustavo Henrique, Siqueira, Sheila, Galapo Kann, Ariel, Dzik, Carlos
Format: Artigo
Idioma:Inglês
Publicat: PAGEPress Publications, Pavia, Italy 2013
Matèries:
Case Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3804819/
https://ncbi.nlm.nih.gov/pubmed/24179656
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4081/rt.2013.e44
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars